Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1508 of 5804
-
Pre-surgery boot camp aims to cut complications in pancreatic cancer patients
Disease control TerminatedMajor digestive surgery is associated with a significant rate of postoperative complications. To improve postoperative outcome, efforts are focused on postoperative course leading to the concept of rehabilitation. However, the rehabilitation concept does not allow to improve musc…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Virus therapy takes on Platinum-Resistant ovarian cancer
Disease control OngoingThis is an open-label, phase 1/1b, dose-escalation, multicenter and multinational trial evaluating the safety of oncolytic adenovirus TILT-123 in combination with Pembrolizumab, or Pembrolizumab and Pegylated Liposomal Doxorubicin in patients with platinum resistant or refractory…
Phase: PHASE1, PHASE2 • Sponsor: TILT Biotherapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New amputation technique may restore natural limb movement for amputees
Knowledge-focused OngoingThe agonist-antagonist myoneural interface (AMI) construct, known as the Ewing amputation at the trans-tibial level, has been shown to create a bi-directional neural communication platform as a means of controlling and interpreting proprioceptive feedback from a prosthetic joint.…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
New hope for lupus nephritis: experimental drug VIB4920 enters Mid-Stage trial
Disease control Recruiting nowThis is a multi-center double-blind placebo controlled clinical trial evaluating the efficacy of VIB4920 combined with mycophenolate mofetil (MMF) and prednisone in achieving a renal response in participants with active lupus nephritis (LN).
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a natural supplement soothe chemo nerve damage?
Symptom relief OngoingThis phase II trial tests whether PEA works to relieve the symptoms of chemotherapy-induced peripheral neuropathy in patients with cancer. Chemotherapy-induced peripheral neuropathy refers to a nerve problem that causes pain, numbness, tingling, or muscle weakness in different pa…
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Parent training program aims to ease mental health struggles in foster kids
Symptom relief CompletedThis study capitalizes on an opportunity to formally evaluate local adaptations of "Keeping Foster and Kinship Parents Supported and Trained" (KEEP), an evidence-based foster parent intervention, to reduce mental health disparities among child welfare-involved youth and improve c…
Phase: NA • Sponsor: Oregon Social Learning Center • Aim: Symptom relief
Last updated Jun 26, 2026 13:54 UTC
-
Talking to kids about weight: 6,600 children test coaching approach to fight obesity
Disease control Recruiting nowPrimary care settings lack interventions to address the childhood obesity epidemic that are feasible and sustainable without requiring significant resources. The investigators propose to modify and test an intervention shown to lower children's body mass index(BMI) so that it is …
Phase: NA • Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Jun 26, 2026 14:20 UTC
-
New radiation approach aims to shrink pancreatic tumors in just five sessions
Disease control Recruiting nowThis is an interventional, single-arm, open-label study with high dose short course radiotherapy for patients with locally advanced pancreatic cancer.
Phase: NA • Sponsor: EBG MedAustron GmbH • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Brain aneurysm showdown: which treatment works best?
Disease control Recruiting nowIntracranial aneurysms located on the middle cerebral artery (MCA) are considered by many surgeons to represent a distinct subgroup of aneurysms for which clipping may still be the best management option. Most MCA aneurysms are accessible, proximal control can readily be secured …
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New sinus implant aims to unblock noses and ease facial pain
Symptom relief CompletedMulticenter, phase III, randomized, blinded, controlled, parallel group.
Phase: PHASE3 • Sponsor: Lyra Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New Antibody-Chemo cocktail shows promise for tough lung cancers
Disease control CompletedPhase II open label, multicenter study to evaluate the efficacy and safety of AK104 (anti-PD-1 and CTLA-4 bispecific antibody) combined with Docetaxel in Advanced Non-Small Cell Lung Cancer whose disease has progressed after prior platinum doublet chemotherapy and anti-PD-1/PD-L1…
Phase: PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for young lupus patients: drug trial targets kidney damage
Disease control Recruiting nowThis phase II, randomized, double-blind, placebo-controlled study is designed to evaluate the safety, efficacy and pharmacokinetics (PK) of obinutuzumab in adolescent participants (AP) aged 12 to less than 18 with biopsy-confirmed proliferative lupus nephritis (LN). It will also …
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a Nurse-Led support program ease Families' trauma after ICU?
Disease control CompletedBackground: Family members of critically ill patients face considerable uncertainty and distress during their close other's intensive care unit (ICU) stay, with about 20-60% of family members experiencing post-traumatic distress post-ICU. Guidelines recommend structured family in…
Phase: NA • Sponsor: Rahel Naef • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New combo attack on stubborn head and neck cancers enters early human testing
Disease control Recruiting nowThis phase I trial is to find out the possible side effects of pembrolizumab and radiation therapy before and during surgery in treating patients with head and neck squamous cell cancer that remains despite treatment (persistent) or has come back (recurrent). Immunotherapy with m…
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a headset ease depression at home?
Symptom relief CompletedA two-center trial to investigate whether or not active stimulation with the Flow FL-100 tDCS device is superior to sham stimulation for the treatment of major depressive disorder when used at home. Participants perform up to 36 tDCS sessions by themselves without supervision du…
Phase: NA • Sponsor: Flow Neuroscience AB • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Wearable sensors may personalize balance rehab for older adults — a trial puts them to the test
Symptom relief Recruiting nowThe proposed research is relevant to vestibular science and the general public because age-related vestibular hypofunction is a major contributor to poor balance, falls, and other adverse health outcomes. In this investigation the investigators will: 1) assess the preliminary eff…
Phase: NA • Sponsor: University of Montana • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Electric field therapy for brain tumors: a new hope?
Disease control Recruiting nowThis clinical trial tests the safety and side effects of tumor treating fields in treating patients with gliomas located in the brainstem. Optune is a wearable, portable, treatment that creates low-intensity, wave-like electric fields called tumor treating fields (TTFields), whic…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New targeted drug shows promise for Hard-to-Treat breast cancers
Disease control Recruiting nowThe main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-783. LOXO-783 may be used to treat breast cancer and other solid tumors that have a change in a particular gene (known as the PIK3CA gene). Participation could last up to 36 …
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Breathing new life: rehab program aims to ease lingering symptoms after blood clots in lungs
Symptom relief Recruiting nowPulmonary Embolism (PE) is a common and serious disease. Indeed, the annual incidence is 1/1000 patients per year and the 3-month mortality is 10%, which is twice that of myocardial infarction. The treatment is based on anticoagulation for at least 3 months. However, after three …
Phase: NA • Sponsor: University Hospital, Brest • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New PET scan could spot hidden diseases early
Diagnosis Recruiting nowThis prospective, single-center study investigates the biodistribution, dosimetry, safety, diagnostic performance of Al18F-NOTA-FAPI PET imaging in patients with malignant tumor,cardiovascular or immune disease. And evaluates the potential of Al18F-NOTA-FAPI PET imaging in Clinic…
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC